Johanna E. Markkanen
Publications by Year
Research Areas
Angiogenesis and VEGF in Cancer, Lymphatic System and Diseases, Virus-based gene therapy research, Electrospun Nanofibers in Biomedical Applications, Peripheral Artery Disease Management
Most-Cited Works
- → VEGF-D Is the Strongest Angiogenic and Lymphangiogenic Effector Among VEGFs Delivered Into Skeletal Muscle via Adenoviruses(2003)441 cited
- → Adenoviral Catheter-Mediated Intramyocardial Gene Transfer Using the Mature Form of Vascular Endothelial Growth Factor-D Induces Transmural Angiogenesis in Porcine Heart(2004)190 cited
- → Expression of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 (KDR/Flk-1) in Ischemic Skeletal Muscle and Its Regeneration(2002)188 cited
- → Fibroblast growth factor‐4 induces vascular permeability, angiogenesis, and arteriogenesis in a rabbit hind limb ischemia model(2002)148 cited
- → Blood Flow Remodels Growing Vasculature During Vascular Endothelial Growth Factor Gene Therapy and Determines Between Capillary Arterialization and Sprouting Angiogenesis(2005)118 cited
- → Gene Therapy for Ischemic Cardiovascular Diseases: Some Lessons Learned from the First Clinical Trials(2004)86 cited
- → Gene transfer into rabbit arteries with adeno‐associated virus and adenovirus vectors(2004)70 cited
- → 15-Lipoxygenase-1 Prevents Vascular Endothelial Growth Factor A– and Placental Growth Factor–Induced Angiogenic Effects in Rabbit Skeletal Muscles via Reduction in Growth Factor mRNA Levels, NO Bioactivity, and Downregulation of VEGF Receptor 2 Expression(2007)52 cited
- → Distinct Architecture of Lymphatic Vessels Induced by Chimeric Vascular Endothelial Growth Factor-C/Vascular Endothelial Growth Factor Heparin-Binding Domain Fusion Proteins(2007)38 cited
- → Novel Vascular Endothelial Growth Factor D Variants with Increased Biological Activity(2009)32 cited